AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25716702
Drug: Dexamethasone (Dexsol®,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (Dexsol®, Rosemont Pharmaceuticals Ltd) 6 mg daily for 5 days, started within 24 hours of admission.
Trial: 19324916
Drug: T3 (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T3 (0.8 microg kg(‐1) bolus; 0.113 microg kg(‐1) h(‐1) infusion)
Trial: 19324916
Drug: Methylprednisolone (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1000 mg bolus)
Trial: 17531887
Drug: High-dose NaFeEDTA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose NaFeEDTA (56 mg/kg)
Trial: 7527406
Drug: 17 beta-estradiol
RxNorm normalized name: 17 beta-estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol (E2) 10 mg E2 valerate
Trial: 16618907
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of surgery, radiation therapy, and chemotherapy (cisplatin and paclitaxel) along with intraoperative radiation therapy
Trial: 18548234
Drug: 14-mg transdermal
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 14-mg transdermal nicotine patch
Trial: 10087976
Drug: Single 4-hour
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single 4-hour infusion of 1500 mg Clodronate
Trial: 10087976
Drug: Traditional 2-hour
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional 2-hour infusion of 300 mg Clodronate
Trial: 8092591
Drug: Intranasal sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal sufentanil and midazolam (IN‐SM)
Trial: 8092591
Drug: Intramuscular meperidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular meperidine, promethazine, and chlorpromazine (IM‐MPC)
Trial: 9686822
Drug: rhG‐CSF (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhG‐CSF (10 microg/kg) administered for 3 consecutive days (0, 1, 2)
Trial: 21109462
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion of 0.2 μg/kg/min (Group 2)
Trial: 10677394
Drug: Intraduodenal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraduodenal administration of lactulose and rhamnose with accelerated small-bowel transit
Trial: 9313390
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity weight‐bearing exercise program (thrice‐weekly for 12 weeks)
Trial: 9313390
Drug: Minimal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal treatment (education program only)
Trial: 8458054
Drug: Cefadroxil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil (30 mg/kg once daily for 10 days)
Trial: 8458054
Drug: Cephalexin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin (30 mg/kg/day in two divided doses for 10 days)
Trial: 22980168
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation size enlarged to 2 sizes larger than FABF (Group A)
Trial: 22980168
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation size enlarged to 3 sizes larger than FABF (Group B)
Trial: 22980168
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation size enlarged to 4 sizes larger than FABF (Group C)
Trial: 22980168
Drug: Apical preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apical preparation size enlarged to 6 sizes larger than FABF (Group E)
Trial: 20180916
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) as initial therapy
Trial: 10356736
Drug: Act-Hib vaccine
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Act-Hib vaccine
Trial: 7497560
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg with sodium citrate/bicarbonate
Trial: 29618012
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg methylphenidate
Trial: 6812106
Drug: 0.50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 mg/kg methylphenidate
Trial: 18692788
Drug: Luteal phase
RxNorm normalized name: Nuphar lutea leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luteal phase support with vaginal progesterone gel (Crinone 8% gel)
Trial: 25245190
Drug: Ritonavir-boosted atazanavir
RxNorm normalized name: atazanavir and ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted atazanavir (300 mg/100 mg) with 0.35 mg norethindrone
Trial: 25245190
Drug: Other antiretroviral
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antiretroviral therapy known to not alter norethindrone levels
Trial: 9394096
Drug: Testosterone cypionate
RxNorm normalized name: Testosterone Cypionate
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone cypionate (TC) 100 mg/wk
Trial: 9394096
Drug: Testosterone cypionate
RxNorm normalized name: Testosterone Cypionate
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone cypionate (TC) 250 mg/wk
Trial: 9394096
Drug: Testosterone cypionate
RxNorm normalized name: Testosterone Cypionate
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone cypionate (TC) 500 mg/wk
Trial: 3371838
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide (4 mg)
Trial: 14766687
Drug: Clear ocular
RxNorm normalized name: Caladryl Clear
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clear ocular hydro-gel (Vidisic)
Trial: 14766687
Drug: Ocular dexpanthenol
RxNorm normalized name: Dexpanthenol
DrugBank: Dexpanthenol (DB09357)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ocular dexpanthenol ointment (Oleovit)
Trial: 12390061
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant (acenocoumarol, INR 2-3)
Trial: 23709304
Drug: Oxycodone CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone CR
Trial: 21842158
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose (0.5 g/l)
Trial: 21842158
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (1 g/l)
Trial: 21842158
Drug: Placebo dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo dose (0 g/l)
Trial: 19637645
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available phenol-based formulation
Trial: 19637645
Drug: New softening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New softening agent formulations
Trial: 11255933
Drug: Combined pharmacological
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined pharmacological and behavioral treatments
Trial: 9738781
Drug: Calcipotriene ointment
RxNorm normalized name: Calcipotriene Ointment
DrugBank: Calcipotriol (DB02300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcipotriene ointment on weekdays and halobetasol ointment on weekends
Trial: 9738781
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment on weekdays and halobetasol ointment on weekends
Trial: 320478
Drug: Dextroamphetamine 10
RxNorm normalized name: dextroamphetamine 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine 10 mg with morphine
Trial: 320478
Drug: Dextroamphetamine 5
RxNorm normalized name: dextroamphetamine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine 5 mg with morphine
Trial: 320478
Drug: Morphine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine alone (3, 6 or 12 mg)
Trial: 28140641
Drug: Physical rehabilitation
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical rehabilitation with sham photobiomodulation treatment
Trial: 26166378
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone (5 mg)
Trial: 21727006
Drug: Ibandronate 6
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 6 mg infused over 15 min and 60 min
Trial: 11506105
Drug: Acupuncture (intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (intradermal needles inserted at acupoints 2.5 cm from the spinal vertebrae)
Trial: 22311378
Drug: Oxazepam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (30 mg)
Trial: 2894218
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg temazepam
Trial: 31433781
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control group receiving no active treatment.
Trial: 21171525
Drug: Ringerfundin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ringerfundin infusion
Trial: 9814085
Drug: Chronic dietary
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic dietary fibre supplementation (doubled from 17.5 g/day to 34.4 g/day)
Trial: 23014494
Drug: Mothers supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mothers supplemented with 2 doses of 200,000 iu retinol (n = 13)
Trial: 19542901
Drug: Alglucosidase alpha
RxNorm normalized name: Alglucosidase alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alglucosidase alpha 40 mg/kg biweekly
Trial: 19542901
Drug: Alglucosidase alpha
RxNorm normalized name: Alglucosidase alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alglucosidase alpha treatment
Trial: 2824623
Drug: 5 X
RxNorm normalized name: PAD,ABDOMINAL 5 X 9 STERILE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 X 10(4) units of human leukocyte interferon/kg of body weight for 12 doses over 14 days (total, approximately 3.6 X 10(7) units)
Trial: 28512158
Drug: Subcutaneous abdominal
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous abdominal fat
Trial: 9931196
Drug: Ibuprofen (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (1.2 g/day)
Trial: 2688360
Drug: 3 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g/day of TISACID (acid‐neutralizing capacity = 78 mmol)
Trial: 22020354
Drug: Casopitant 30
RxNorm normalized name: casopitant
DrugBank: Casopitant (DB06634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casopitant 30 mg/d
Trial: 22020354
Drug: Casopitant 120
RxNorm normalized name: casopitant
DrugBank: Casopitant (DB06634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casopitant 120 mg/d
Trial: 22020354
Drug: Paroxetine 30
RxNorm normalized name: PARoxetine 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 30 mg/d
Trial: 19410509
Drug: Pregabalin 300mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300mg, 450mg, and 600mg daily
Trial: 2839000
Drug: Rubber cup
RxNorm normalized name: Aspergillus ruber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rubber cup with standardized solution of pumice
Trial: 31797680
Drug: Selective internal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective internal radiation therapy (SIRT) using 90yttrium resin microspheres
Trial: 19500141
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration with isotonic saline + N-acetylcysteine (600 mg p.o. twice daily the preceding day and the day of angiography), n = 73
Trial: 19500141
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration with isotonic saline, n = 72
Trial: 16838577
Drug: Enhanced External
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced External Counterpulsation (EECP) treatment
Trial: 30035670
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG) - maintained daily physical activities (n=18)
Trial: 24083350
Drug: Pantoprazole treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole treatment until esophageal mucosal healing
Trial: 19185645
Drug: Anacetrapib 300
RxNorm normalized name: Anacetrapib
DrugBank: Anacetrapib (DB06630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anacetrapib 300 mg once daily for 8 weeks
Trial: 19185645
Drug: Anacetrapib coadministered
RxNorm normalized name: Anacetrapib
DrugBank: Anacetrapib (DB06630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anacetrapib coadministered with atorvastatin 20 mg
Trial: 14692989
Drug: Weekly visits
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly visits to supervise diet, exercise, medication education, and self-monitoring blood sugar (Group II)
Trial: 14692989
Drug: Group I
RxNorm normalized name: Platelet group IIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group I (Daily visits)
Trial: 14692989
Drug: Group II
RxNorm normalized name: Platelet group IIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group II (Weekly visits)
Trial: 11720834
Drug: Dexamethasone plus
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone plus ondansetron 8 mg daily (arm B) on days 2-4
Trial: 31475623
Drug: Saffron extract
RxNorm normalized name: saffron extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saffron extract (affron®, 14 mg b.i.d.)
Trial: 25054387
Drug: Transforaminal (TF)
RxNorm normalized name: transforming growth factor beta 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal (TF) epidural injection of methylprednisolone (80 mg)
Trial: 21114202
Drug: Generic Pioglitazone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic Pioglitazone (Utmos) 30 mg/day for 24 weeks
Trial: 15795426
Drug: Carnitine supplement
RxNorm normalized name: carnitine
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carnitine supplement
Trial: 12760312
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg EGCG
Trial: 12760312
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg EGCG
Trial: 15580809
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg EGCG
Trial: 15580809
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg EGCG
Trial: 15580809
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg EGCG
Trial: 12760312
Drug: 1600 mg
RxNorm normalized name: glycerin 1600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg EGCG
Trial: 15230341
Drug: Cefaclor extended
RxNorm normalized name: Cefaclor Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor extended release 500‐mg tablet after high‐fat vegetarian diet
Trial: 15230341
Drug: Cefaclor extended
RxNorm normalized name: Cefaclor Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor extended release 500‐mg tablet after overnight fasting
Trial: 29046301
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D inadequacy (serum 25-hydroxyvitamin D concentration <50 nmol/L)
Trial: 21712713
Drug: Microneedles for
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microneedles for lidocaine injection
Trial: 21712713
Drug: Hypodermic needles
RxNorm normalized name: Neolus Hypodermic Needles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypodermic needles for lidocaine injection (control)
Trial: 9694705
Drug: All-trans retinoic
RxNorm normalized name: all trans Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-trans retinoic acid (RA) in combination with daunorubicin and cytarabine (DA)
Trial: 31566680
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy plus endocrine therapy
Trial: 17227688
Drug: High-potency zoster
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-potency zoster vaccine (approximately 207,000 plaque-forming units/dose)
Trial: 17227688
Drug: Low-potency zoster
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-potency zoster vaccine (approximately 58,000 plaque-forming units/dose)
Trial: 17227688
Drug: High-potency zoster
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-potency zoster vaccine
Trial: 17227688
Drug: Low-potency zoster
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-potency zoster vaccine
Trial: 24187870
Drug: Sini injection
RxNorm normalized name: Ephedra sinica root
DrugBank: Ephedra sinica root (DB01363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sini injection (SG)
Trial: 16759769
Drug: Separate DTaP
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate DTaP and IPV vaccines
Trial: 18316985
Drug: Combined DTaP-IPV
RxNorm normalized name: DTaP-IPV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined DTaP-IPV vaccine
Trial: 8981527
Drug: rHuEPO administered
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO administered subcutaneously three times weekly (group A)
Trial: 8981527
Drug: rHuEPO administered
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO administered subcutaneously once weekly (group B)
Trial: 20462570
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy (MBCT) plus treatment as usual (TAU)
Trial: 2083097
Drug: Curosurf (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curosurf (200 mg/kg) via the tracheal tube
Trial: 2776469
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg diflunisal twice daily
Trial: 359248
Drug: 65 mg
RxNorm normalized name: opium 65 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 65 mg dextropropoxyphene plus 650 mg paracetamol 3-times daily
Trial: 31613825
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (HT) duration
Trial: 22187760
Drug: Prophylactic intramuscular
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic intramuscular ephedrine 0.5 mg/kg given 10 minutes before spinal anaesthesia
Trial: 22187760
Drug: Prophylactic intramuscular
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic intramuscular ephedrine 0.5 mg/kg given 20 minutes before spinal anaesthesia
Trial: 22187760
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Group C) received only preloading with 15 ml/kg of Ringer lactate solution
Trial: 11488779
Drug: Ebastine 60
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine 60 mg/day
Trial: 11488779
Drug: Ebastine 100
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine 100 mg/day
Trial: 11488779
Drug: Terfenadine 360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 360 mg/day
Trial: 9669009
Drug: bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.5% 38 ml + 10 mg midazolam (Group M10)
Trial: 9669009
Drug: bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.5% 36 ml + 20 mg midazolam (Group M20)
Trial: 2428795
Drug: MOPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP chemotherapy
Trial: 25380222
Drug: Individualized guided
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized guided internet-delivered cognitive-behavioral therapy for 8 weeks
Trial: 19614942
Drug: Vildagliptin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin (100 mg)
Trial: 14628981
Drug: Modafinil (100-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (100-400 mg once daily)
Trial: 9138543
Drug: Pethidine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine (0.3 mg x kg‐1)